IDO2 and neoplasm: Additionally, the anti-tumor immunological response is improved by an increase in SCFA, valeric acid abundance, imbalances of indoleamine 2,3-dioxygenase (IDO) activity, and an increase in L-tryptophan production and a decrease in L-kynurenine production in addition to the kynurenine/tryptophan ratio.